Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 45, Status: Authorised
Clinical investigation of medicinal products in the treatment of Parkinson's disease - Scientific guideline
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease
Minutes - Management Board meeting: 2 October 2025
Appendix 1: Acceptable intakes established for N-nitrosamines
Stakeholders and Communication
National competent authorities (veterinary)
National competent authorities (human)
Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)
Procedural advice for veterinary vaccine antigen master file (VAMF) certification - Procedural Guidance